These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 34927760

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis.
    Black CJ, Burr NE, Quigley EMM, Moayyedi P, Houghton LA, Ford AC.
    Gastroenterology; 2018 Dec; 155(6):1753-1763. PubMed ID: 30144426
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Plecanatide for the treatment of constipation-predominant irritable bowel syndrome.
    Miner PB.
    Expert Rev Gastroenterol Hepatol; 2020 Feb; 14(2):71-84. PubMed ID: 31985305
    [Abstract] [Full Text] [Related]

  • 8. AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation.
    Chang L, Sultan S, Lembo A, Verne GN, Smalley W, Heidelbaugh JJ.
    Gastroenterology; 2022 Jul; 163(1):118-136. PubMed ID: 35738724
    [Abstract] [Full Text] [Related]

  • 9. Diarrhea-Predominant and Constipation-Predominant Irritable Bowel Syndrome: Current Prescription Drug Treatment Options.
    Wechsler EV, Shah ED.
    Drugs; 2021 Nov; 81(17):1953-1968. PubMed ID: 34727333
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and Tolerability of Guanylate Cyclase-C Agonists for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis.
    Shah ED, Kim HM, Schoenfeld P.
    Am J Gastroenterol; 2018 Mar; 113(3):329-338. PubMed ID: 29380823
    [Abstract] [Full Text] [Related]

  • 12. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
    Evans BW, Clark WK, Moore DJ, Whorwell PJ.
    Cochrane Database Syst Rev; 2007 Oct 17; (4):CD003960. PubMed ID: 17943807
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Safety, tolerability and satisfaction with tegaserod therapy in Asia-Pacific patients with irritable bowel syndrome with constipation.
    Fock KM, Wagner A, Asia Pacific Gastroenterology Group.
    J Gastroenterol Hepatol; 2007 Aug 17; 22(8):1190-8. PubMed ID: 17524039
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation.
    Tack J, Müller-Lissner S, Bytzer P, Corinaldesi R, Chang L, Viegas A, Schnekenbuehl S, Dunger-Baldauf C, Rueegg P.
    Gut; 2005 Dec 17; 54(12):1707-13. PubMed ID: 16020489
    [Abstract] [Full Text] [Related]

  • 17. A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation.
    Johnston JM, Shiff SJ, Quigley EM.
    Curr Med Res Opin; 2013 Feb 17; 29(2):149-60. PubMed ID: 23198977
    [Abstract] [Full Text] [Related]

  • 18. Linaclotide: a novel compound for the treatment of irritable bowel syndrome with constipation.
    Rothstein RD, Friedenberg FK.
    Expert Opin Pharmacother; 2013 Oct 17; 14(15):2125-32. PubMed ID: 24007408
    [Abstract] [Full Text] [Related]

  • 19. Current and future pharmacotherapies for the management of constipation-predominant irritable bowel syndrome.
    Biniszewska O, Jacenik D, Tarasiuk A, Fichna J.
    Expert Opin Pharmacother; 2024 Jun 17; 25(8):1039-1049. PubMed ID: 38856704
    [Abstract] [Full Text] [Related]

  • 20. Linaclotide, novel therapy for the treatment of chronic idiopathic constipation and constipation-predominant irritable bowel syndrome.
    Vazquez-Roque MI, Bouras EP.
    Adv Ther; 2013 Mar 17; 30(3):203-11. PubMed ID: 23436110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.